Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma (Pedi CART-19)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by Children's Hospital of Philadelphia
Sponsor:
Collaborator:
University of Pennsylvania
Information provided by (Responsible Party):
Stephan Grupp, Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT01626495
First received: June 18, 2012
Last updated: June 7, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)